Reduction of peristaltic artifacts on magnetic resonance imaging of the abdomen: A comparative evaluation of three drugs

Abdominal Imaging

Volumn 21, Issue 4, 1996, Pages 309-313

  Marti Bonmati L ^a   Graells, M ^a   Ronchera Oms, C L ^b  

^a HOSPITAL UNIVERSITARIO DR PESET   (Spain)

^b UNIVERSIDAD CEU CARDENAL HERRERA   (Spain)

Author keywords

Butylscopolamine; Dicyclomine; Gastrointestinal tract, MR; Glucagon; MR, artifact; MR, noise reduction

Indexed keywords

BARIUM SULFATE; CHOLINERGIC RECEPTOR BLOCKING AGENT; DICYCLOVERINE; GLUCAGON; SCOPOLAMINE BUTYL BROMIDE;

ADULT; AGED; ARTICLE; ARTIFACT REDUCTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; IMAGE ANALYSIS; IMAGE QUALITY; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; ORAL DRUG ADMINISTRATION; PERISTALSIS; PRIORITY JOURNAL; SINGLE BLIND PROCEDURE;

ABDOMEN; ADMINISTRATION, ORAL; ADULT; AGED; ARTIFACTS; BUTYLSCOPOLAMMONIUM BROMIDE; DICYCLOMINE; FEMALE; GASTROINTESTINAL AGENTS; GLUCAGON; HUMANS; IMAGE ENHANCEMENT; IMAGE PROCESSING, COMPUTER-ASSISTED; INJECTIONS, INTRAVENOUS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MUSCARINIC ANTAGONISTS; PARASYMPATHOLYTICS; PERISTALSIS; PROSPECTIVE STUDIES; SINGLE-BLIND METHOD;

EID: 0029902061     PISSN: 09428925     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002619900070     Document Type: Article

References (20)

1. Bellon EM, Haacke EM, Coleman PE, et al. MR artifacts: a review. AJR 1986;147:1271-1281
2. Wood ML, Runge VM, Henkelman RM. Overcoming motion in abdominal MR imaging. AJR 1988;150:513-522
3. Stark DD, Hendrick RE, Hahn PF, et al. Motion artifact reduction with fast spin-echo imaging. Radiology 1987;164:183-191
4. Weinreb JC, Maravilla KR, Redman HC, et al. Improved MR imaging of the upper abdomen with glucagon and gas. J Comput Assist Tomogr 1984;8:835-838
5. Chou CK, Liu GC, Yang LT, et al. Abdominal MR imaging following antegrade air introduction into the intestinal loops. Abdom Imaging 1993;18:205-210
6. Martí-Bonmatí L, Vilar J, Paniagua JC, et al. High density barium sulphate as a MR contrast agent in MRI. Mag Reson Imaging 1991;9:259-261
7. Brown JJ, Duncan JR, Heiken JP, et al. Perfluoroctylbromide as a gastrointestinal contrast agent for MR imaging: use with and without glucagon. Radiology 1991;181:455-460
8. Kaminsky S, Laniado M, Gogoll M, et al. Gadopentetate dimeglumine as a bowell contrast agent: safety and efficacy. Radiology 1991;178:503-508
9. Winkler ML, Hricak H. Pelvis imaging with MR: technique for improvement. Radiology 1986;158:848-849
10. Stark DD, Wittenberg J, Edelman RR, et al. Detection of hepatic metastases: analysis of pulse sequence performance in MR imaging. Radiology 1986;159:365-370
11. Kaufman L, Kramer DM, Crooks LE, et al Measuring signal-to-noise ratios in MR imaging. Radiology 1989;173:265-267
12. Maglinte DDTM, Chernish SM. The optinal dose of glucagon: what is enough? Radiology 1992;183:326-327
13. Miller RE, Chernish SM, Brunelle RL, et al. Double-blind radiographic study of dose response to intravenous glucagon for hypotonic duodenography. Radiology 1978;127:55-59
14. Skucas J. Optimal dose of glucagon. Radiology 1992;183:325
15. AHFS. Glucagon. In: McEvoy GK, ed. Drug information 94. Bethesda: American Society of Hospital Pharmacy Inc. 1994: 2075-2076
16. Moeller G, Hughes JJ, Mangano FA, et al. Comparison of L-hyoscyamine, glucagon, and placebo for air-contrast upper gastrointestinal series. Gastrointest Radiol 1992;17:195-198
17. Bova JG, Jurdi RA, Bennett WF. Antispasmodic drugs to reduce discomfort and colonic spasm during barium enemas: comparison of oral hyoscyamine, IV glucagon, and no drug. AJR 1993;161: 965-968
18. Kozak RI, Bennett JD, Brown TC, et al. Reduction of bowel motion artifact during digital subtraction angiography: a comparison of hyoscine butylbromide and glucagon. Can Assoc Radiol J 1994;45:209-211
19. Braccini G, Marraccini P, Marrucci A, et al. Usefulness and safety of pirenzepine in double-contrast study of upper gastrointestinal tract: comparison with scopolamine methylbromide. Abdom Imaging 1994;19:201-206
20. Skucas J. The use of antispasmodic drugs during barium enemas. AJR 1994;162:1323-1325